This was reported on the FMBA website.
It is noted that “more than 500 volunteers aged 18 to 60 years took part in the clinical studies of Flu-M Tetra”.
“Next year the drug will receive an expansion according to indications for use in children and the elderly.
According to such an indicator as an assessment of immunogenicity, the vaccine "Flu-M Tetra" showed superior results compared to the comparison drug, "the report says.
The FMBA said that "the new vaccine forms immunity against four current strains of the influenza virus according to WHO recommendations."
Earlier, the former chief sanitary doctor of Russia, Gennady Onishchenko, at an online briefing on the NSN urged Russians to be vaccinated against COVID-19.